FluoGuide A/S submits phase I/II Clinical Trial Application

Copenhagen, Denmark, 6 July 2020 – FluoGuide A/S (“FluoGuide” or “the Company”) today submitted a Clinical Trial Application for the proof-of-concept clinical phase I/II trial of FG001 for use in guiding surgery of aggressive brain cancer (glioblastoma).

The release as fetched from its publisher. fluoguide.com ↗